AdvanCell Isotopes Pty Ltd
Gary Li, Ph.D, serves as the Chief Strategy Officer at AdvanCell and previously held the position of VP, Head of Oncology Research at IGNYTA, Inc. With a strong background in oncology research, Gary Li has played a pivotal role in driving strategic initiatives within the life sciences sector.
This person is not in any teams
This person is not in any offices
AdvanCell Isotopes Pty Ltd
AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.